|
21 Apr 2007 |
Cleveland BioLabs Protectan CBLB612 Demonstrates Efficacy in Stimulating Proliferation and Mobilization of Bone Marrow Stem Cells in Primate Model
|
|
20 Apr 2007 |
Aranesp(R) ''145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
|
|
19 Apr 2007 |
Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD. Phase III clinical trial may commence shortly
|
|
19 Apr 2007 |
Viragen Announces European Multiferon(R) Licensing Agreement
|
|
18 Apr 2007 |
Dyax Initiates Confirmatory Phase 3 (EDEMA4) Trial for DX-88 for the Treatment of Hereditary Angioedema
|
|
18 Apr 2007 |
DeveloGen and Andromeda, a newly formed wholly-owned subsidiary of Clal Biotechnology Industries, Sign Term Sheet for Asset Purchase Agreement for the DiaPep277(R) Program
|
|
18 Apr 2007 |
Adnexus Therapeutics Announces Presentation at the American Association for Cancer Research (AACR) on Clinical Product Candidate, CT-322
|
|
18 Apr 2007 |
Prevascar Phase II Results
|
|
18 Apr 2007 |
OncoGenex Technologies Announces Phase II Data of OGX-011 in Metastatic
|
|
17 Apr 2007 |
Preclinical Data Show Alfacell's ONCONASE(R) Inhibits Tumor Growth of Non-Small Cell Lung Cancer, Breast Cancer Cells Poster Presented at AACR Annual Meeting
|
|
17 Apr 2007 |
Aranesp(R) Phase 3 Study in Patients with Active Cancer Not Receiving Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual Meeting
|
|
15 Apr 2007 |
Human Genome Sciences Reports Positive Interim Results of Phase 2b Trial of Albuferon(R)
|
|
13 Apr 2007 |
Affymax(R) Announces Results From Phase 2 Clinical Trial of Hematide(TM) for the Treatment of Anemia in Dialysis Patients
|
|
13 Apr 2007 |
Intarcia Therapeutics Announces Final Results From A Phase 2 Study Of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1
|
|
13 Apr 2007 |
DX-88 for Hereditary Angioedema Meets Primary and Secondary Endpoints in Phase 3 Trial (EDEMA3(R))
|
|
12 Apr 2007 |
Follistim(R) introduced in Japan in a further indication for the treatment of infertility
|
|
12 Apr 2007 |
Nuvelo Announces Publication of NU206 Study Results in Gastroenterology
|
|
11 Apr 2007 |
Stem Cell Therapeutics Corp. Announces Positive Interim Results From its Currently Enrolling Phase IIa Clinical Program for NTx(TM)-265 in Acute Stroke
|
|
06 Apr 2007 |
PEGINTRON(TM) Approved in China for Treating Chronic Hepatitis B
|
|
05 Apr 2007 |
Eurand Announces Positive Phase III Clinical Study Results
|
|
04 Apr 2007 |
Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate
|
|
04 Apr 2007 |
New Data Confirm That Use of Levemir Can Limit Weight Gain
|
|
04 Apr 2007 |
Targanta Reports Improved Ability of Oritavancin to Stop Bacteria Growth In Vitro Compared With Other Glycopeptide Antibiotics
|
|
03 Apr 2007 |
Nautilus Biotech begins Phase I clinical trial in the USA for subcutaneous Belerofon(R) its long-lasting, Interferon-alpha drug.
|
|
03 Apr 2007 |
Helix BioPharma Corp. announces positive phase II clinical results with its Topical Interferon Alpha-2b
|
